Case ID: ct-intl-trade_34/html/1423-01.html
Source: Caselaw Access Project
Author: {"author": "STANCEU, Judge:", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

United States, Plaintiff, v. Callanish Ltd., Defendant.
    Court No. 03-00658
    Dated: November 2, 2010
    
      Tony West, Assistant Attorney General, Jeanne E. Davidson, Director, Commercial Litigation Branch, Civil Division, United States Department of Justice (Domenique Kirchner); Kevin B. Marsh, Bureau of Customs and Border Protection, of counsel, for plaintiff.
   OPINION AND ORDER

STANCEU, Judge:

Following the court’s opinion and order in United States v. Scotia Pharmaceuticals Ltd., 33 CIT _, Slip Op. 09-49 (May 20, 2009), plaintiff filed an amended complaint to recover a civil penalty under Section 592 of the Tariff Act of 1930, as amended, 19 U.S.C. § 1592 (1988) (“Section 592”) against defendant Callanish Ltd. (“Callanish”) in the amount of $17,734,926. Am. Compl. ¶¶ 91-93. Plaintiff’s claim arises out of fifty-two consumption entries of merchandise, made between September 1, 1988 and March 24, 1992, that plaintiff alleges to have been capsules of “evening primrose oil” (“EPO”), a substance used as a food additive that could not be imported lawfully at the time of the entries at issue. Id. ¶¶ 11-12, 91-93. After defendant failed to appear by licensed counsel and failed to plead or otherwise defend itself within twenty days of being served with the summons and the amended complaint, the Clerk of this Court, pursuant to USCIT Rules 12 and 55, entered Callanish’s default. Entry of Default 1.

On May 19, 2010, plaintiff applied for a judgment by default against Callanish in the amount of $17,734,926 pursuant to USCIT Rule 55(b). Pl.’s Req. for Default J. as to Callanish Ltd. 1-2 (“Pl.’s Req. for Default J.”). Upon review of the amended complaint and plaintiff’s application, the court holds that plaintiff has not established its entitlement to the default judgment it seeks against Callanish because plaintiff has failed to set forth as a well-pled fact the domestic value of the merchandise plaintiff alleges to have been imported fraudulently. The court, therefore, will deny without prejudice plaintiff’s application for a default judgment.

I. Background

A. Alleged Fraudulent Scheme to Unlawfully Import Evening Primrose Oil

The amended complaint alleges that beginning on February 12, 1985, the Food and Drug Administration (“FDA”) issued a series of import alerts announcing that evening primrose oil coüld not be sold lawfully in the United States without FDA approval, that this substance did not have FDA approval, and that all import shipments of EPO offered for entry into the United States were to be detained by Customs and Border Protection (“Customs”) and naming Efamol Research, Inc. as a seller of EPO. Am. Compl. ¶ 5; Pl.’s Req. for Default J. 5; Admin. R. Doc. Nos. 70-75.

The amended complaint further alleges that during the period from September 1, 1988 to March 24, 1992, Callanish introduced, or aided and abetted another to enter or introduce, into the United States merchandise consisting of capsules of EPO under cover of fifty-two consumption entries filed at various ports of entry throughout the United States by means of material and false acts, statements and/or material omissions, in violation of Section 592. Am. Compl. ¶¶ 11-12, 91-93; Admin. R. Doc. Nos. 1-12 (Declaration of Timothy F. Quinn, Special Agent, U.S. Immigration and Customs Enforcement).

Plaintiff identifies several main participants in the alleged fraudulent scheme: (1) Murdock Healthcare, “the real buyer and importer” (a U.S. company doing business under several names such as Health Products International (“HPI”)); (2) Chester Lockard, the “straw buyer and importer of record” in the United States who served as president of the two U.S. companies, Pine Lawn Farms, Inc., and Genesis II of Mid-America, that paid the duties and fees for EPO shipments and then billed HPI for the shipments, plus commission; and (3) three subsidiaries of Scotia Pharmaceuticals Ltd. (“Scotia Pharmaceuticals”), a British company: Efamol Ltd. (the British distributor of EPO), Efamol Research, Inc., the successor of which is Quantanova, Canada, Ltd. (“Quantanova”), and defendant Callanish, a British corporation with a business address at Breasclete, Isle of Lewis, Scotland, United Kingdom, that manufactured and shipped the EPO to the United States. Am. Compl. ¶¶ 6-10; Pl.’s Req. for Default J. 3-4.

Specifically, plaintiff alleges that Callanish, as the party responsible for shipping each of the fifty-two entries of EPO to the United States, performed the following acts in furtherance of the fraudulent scheme: (1) “Callanish followed HPI’s instructions to ship the EPO . .

. and not to list or describe the merchandise as EPO;” (2) “Callanish provided false invoices to HPI showing the buyer as Pine Lawn Farms rather than HPI;” and (3) “Callanish, together with Scotia Pharmaceuticals Ltd[.], and Quantanova, Canada, Ltd., used different invoices for the same shipment, an invoice accurately identifying the merchandise as EPO was sent to HPI, and a second invoice was sent to Mr. Lockard’s companies, Pine Lawn Farms or Genesis II, which disguised the EPO in the shipments.” Am. Compl. ¶ 16. Plaintiff claims that the documents submitted to Customs for the fifty-two consumption entries of EPO “contained materially false statements,” Am. Compl. ¶¶ 19-22, and that “Callanish shipped the EPO with knowledge that the importation of the EPO into the United States was illegal and that the EPO would be entered under cover of false documents,” Am. Compl. ¶ 24.

B. Procedural History

The procedural background of this litigation is presented in the court’s opinion and order in United States v. Scotia PharmaceuticalsLtd., 33 CIT _, _, Slip Op. 09-49, at 4-6, and is further supplemented herein.

On May 20, 2009, the court held that plaintiff had not established its entitlement to the judgment by default that it then sought against defendant Callanish for a civil penalty under 19 U.S.C. § 1592. United States v. Scotia Pharmaceuticals Ltd., 33 CIT at _, Slip Op. 09 — 49, at 13-14. The court denied plaintiff’s application for default but also allowed plaintiff the opportunity to amend its complaint. Id. at Slip Op. 09-49, at 14. Because plaintiff had not effected service upon defendants Scotia Pharmaceuticals and Quantanova, the court granted plaintiff’s request to dismiss the action as to those defendants. Id.

On July 31, 2009, plaintiff filed its amended complaint. Am. Compl. On May 17, 2010, after plaintiff successfully effected service of process úpon Callanish, defendant again failed to appear by licensed counsel and failed to plead or otherwise defend itself within twenty days of being served with the summons and amended complaint, and the Clerk of this Court, pursuant to USCIT Rules 12 and 55, entered Callanish’s default. Pl.’s Req. for Default J. 1; Entry of Default 1.

On May 19, 2010, plaintiff applied for a judgment by default against Callanish pursuant to USCIT Rule 55(b). Pl.’s Req. for Default J. 1. Plaintiff seeks a penalty equal to what it alleges to be the domestic value of the EPO entered on the fifty-two entries, $17,734,926. Id. 2.

II. Discussion

Because defendant Callanish has been found to be in default, the court accepts as true all well-pled facts in the complaint. See Au Bon Pain Corp. v. Artect, Inc., 653 F.2d 61, 65 (2d Cir. 1981). An entry of default, however, is not sufficient to entitle plaintiff to the relief it seeks. See Nishimatsu Constr. Co. v. Houston Nat’l Bank, 515 F.2d 1200, 1206 (5th Cir. 1975) (“[A] defendant’s default does not in itself warrant the court in entering a default judgment.”). Even after an entry of default, “it remains for the court to consider whether the unchallenged facts constitute a legitimate cause of action, since a party in default does not admit mere conclusions of law.” 10A Charles A. Wright, Arthur R. Miller & Mary K. Kane, Federal Practice and Procedure § 2688, at 63 (3d ed. 1998); see also Nishimatsu Constr. Co., 515 F.2d at 1206-08 (vacating district court’s entry of default judgment because the pleadings were insufficient to support the judgment). “There must be a sufficient basis in the pleadings for the judgment entered.”Nishimatsu Constr. Co., 515 F.2d at 1206. Accordingly, the court must decide whether the well-pled facts in plaintiff’s complaint, and deemed to be admitted by Callanish as a result of the entry of default, are sufficient to establish liability for a violation of Section 592(a) that is grounded in fraud and sufficient to establish the amount of the civil penalty sought by plaintiff.

Under Section 592(a)(1)(A), it is unlawful for any person to enter, introduce, or attempt to enter or introduce any merchandise into the commerce of the United States by means of material and false documents, statements, or acts or material omissions, whether by fraud, gross negligence, or negligence. 19 U.S.C. § 1592(a)(l)(A)(i)-(ii). The statute also prohibits the aiding and abetting of another to commit a violation of Section 592(a)(1)(A). Id. § 1592(a)(1)(B). In an action brought to recover a civil penalty under Section 592, the amount of the penalty is determined by the court de novo. Id. § 1592(e). The statute provides that a violation of Section 592(a) based on fraud “is punishable by a civil penalty in an amount not to exceed the domestic value of the merchandise.” Id. § 1592(c)(1). Therefore, the domestic value of the merchandise is a fact essential to the court’s de novo determination of the amount of any penalty. Plaintiff, therefore, must allege the domestic value of the merchandise as a well-pled fact in order to obtain a default judgment in this case.

The amended complaint seeks a penalty of $17,734,926, which plaintiff alleges to be the domestic value of the fifty-two consumption entries of EPO that it alleges to have been fraudulently imported in violation of the statute. Am. Compl. ¶ 93. The complaint lacks any well-pled fact concerning the domestic value of the merchandise or how that value was determined. Plaintiff provides only the conclusory statement of the domestic value of the imported EPO. The mere allegation of an amount offered as the “domestic value,” absent anything more, does not constitute a well-pled fact. See Dudnikov v. Chalk & Vermilion Fine Arts, Inc., 514 F.3d 1063, 1070 (10th Cir. 2008) (defining well-pled facts as those that are “plausible, non-conclusory, and non-speculative” (citing Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555-56 (2007) (emphasis added))). Absent such a well-pled fact, the court is unable to enter a judgment by default in this case, and plaintiff’s application must be denied. The court will allow plaintiff the opportunity to move for leave to amend its complaint.

III. Conclusion and Order

From its review of the amended complaint and of plaintiff’s application for judgment by default, the court concludes that plaintiff has not established its entitlement to a judgment by default against defendant Callanish for a civil penalty under 19 U.S.C. § 1592. Upon consideration of all papers and proceedings herein, it is hereby

ORDERED that plaintiff’s application for judgment by default against defendant Callanish be, and hereby is, DENIED without prejudice; and it is further

ORDERED that unless plaintiff moves within sixty (60) days of the date of this Opinion and Order for leave to file an amended complaint, plaintiff, upon entry of a further order, shall be required to show cause why a judgment should not be entered dismissing this action. 
      
       As a consequence of Health. Products International’s (“HPI”) participation in the fraudulent scheme at issue in this action, HPI and its general counsel, Loren Israelson, pleaded guilty in the Eastern District of Missouri in 1996 to violations of 18 U.S.C. § 542 (2006) (entry of goods (EPO) by means of false statements). Am. Compl. ¶ 14. HPI employee David Anderson pleaded guilty to a violation of 19 U.S.C. § 1304 (concealing information regarding the marking of imported goods). Id.
      
     
      
       As a consequence of his participation in the fraudulent scheme at issue in this action, Chester Lockard, president of Pine Lawn Farms, Inc., pleaded guilty to a violation of 18 U.S.C. § 542 for fraudulently importing EPO. Am. Compl. ¶[ 14.
     
      
       From exhibits to plaintiff’s application for judgment by default, it appears that the amount of the “domestic value” was derived by doubling the amounts for entered value as set forth on entry summaries for the importations that are the subject of this action. See Admin. R. Doc. Nos. 165-531.